Journal article
Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
Abstract
Crohn's disease (CD) is an idiopathic inflammatory bowel disease and has no known cure. CD symptoms are treated using an array of medicines, including biological agents such as infliximab. However, infliximab therapy is expensive; therefore, identifying variables that can help predict response to infliximab is worthwhile. The present article reviews the impact of tobacco smoking on the efficacy of infliximab in CD. Earlier studies have …
Authors
Narula N; Fedorak RN
Journal
Canadian Journal of Gastroenterology and Hepatology, Vol. 23, No. 2, pp. 121–125
Publisher
Hindawi
Publication Date
2009
DOI
10.1155/2009/431349
ISSN
2291-2789